Anticancer drug pharmacodynamics
- 1 April 1985
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 14 (3) , 177-183
- https://doi.org/10.1007/bf00258112
Abstract
Summary A considerable amount of information is available on the pharmacokinetics of anticancer drugs, but much less is known of their pharmacodynamics, that is of the relationship between therapeutic or toxic response and drug concentration. Drug dosage regimens which are to achieve defined therapeutic objectives can only be designed when both the pharmacokinetic and the pharmacodynamic characteristics of a drug are known. There are a few reports in the literature of relationships in man between toxic response and pharmacokinetic parameters of anticancer drugs; and an even smaller number of reports of relationships between therapeutic response and pharmacokinetic parameters. It is suggested that the lack of pharmacodynamic information is currently limiting the application of pharmacokinetic information to cancer therapy. Ways of improving knowledge of the pharmacodynamics of anticancer drugs are suggested.Keywords
This publication has 53 references indexed in Scilit:
- Increasing therapeutic response rates to anticancer drugs by applying the basic principles of pharmacologyPharmacology & Therapeutics, 1983
- Dose-Dependent Metabolism, Therapeutic Effect, and Toxicity of Anticancer Drugs in ManDrug Metabolism Reviews, 1983
- Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implicationsEuropean Journal of Cancer and Clinical Oncology, 1982
- Plasma concentrations of carminomycin and carminomycinol in man, measured by high pressure liquid chromatographyEuropean Journal of Cancer and Clinical Oncology, 1982
- Renal toxicity studies of protein-bound platinum(cis)Chemico-Biological Interactions, 1981
- Pharmaco-kinetics of melphalan following oral or intravenous administration in patients with malignant diseasePublished by Elsevier ,1978
- Plasma half-life of cytosine arabinoside in patients with leukaemia—the effect of uridinePublished by Elsevier ,1975
- Properties of the Michaelis-Menten equation and its integrated form which are useful in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Methotrexate toxicity: Correlation with duration of administration, plasma levels, dose and excretion patternPublished by Elsevier ,1972
- Pharmacodynamics of Chemotherapeutic Effects: Dose-Time-Response Relationships for Phase-Nonspecific AgentsJournal of Pharmaceutical Sciences, 1971